The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
exactly what happened with semaglutide and OIC right approved for helping glucose utilization or lowering you know blood glucose in patients with type 2 diabetes and they found through use only people were losing weight and now it's become Blockbuster and it's and we see it with you know things like you know repurposing drugs for cancer right
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.